Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros

Banco de datos
Tipo de estudio
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Talanta ; 17(12): 1191-9, 1970 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-18960850

RESUMEN

The density, viscosity, and electrical conductivity of alkali metal acetates were measured over the temperature interval between melting and decomposition. The apparent activation energies of the equivalent conductivities and viscosities were calculated. It has been concluded from the results that alkali metal acetates, similarly to alkali metal benzenesulphonates studied earlier, exhibit properties quite unlike those of alkali metal halides. In the dependence of equivalent conductivity on the nature of the cation, the anomalous behaviour of lithium salts appears to be due to association prevailing in the melt phase.

2.
J Pharm Biomed Anal ; 11(11-12): 1219-26, 1993.
Artículo en Inglés | MEDLINE | ID: mdl-8123737

RESUMEN

Impurities in drugs are classified on the basis of the types of side-reactions in drug syntheses resulting in their formation. This is shown by summarizing the authors' earlier results in the field of impurity profiling of 19-nor-steroids, ethynodiol diacetate, mazipredone, pipecuronium bromide, flumecinol, enalapril, pyridinol carbamate, phenylbutazone, thymotrinan and some new results related to danazol and famotidine.


Asunto(s)
Química Farmacéutica , Contaminación de Medicamentos , Preparaciones Farmacéuticas/síntesis química , Cromatografía de Gases , Cromatografía Líquida de Alta Presión , Cromatografía en Capa Delgada , Espectroscopía de Resonancia Magnética , Espectrometría de Masas , Preparaciones Farmacéuticas/análisis , Preparaciones Farmacéuticas/aislamiento & purificación , Espectrofotometría Infrarroja , Espectrofotometría Ultravioleta
3.
J Pharm Biomed Anal ; 15(9-10): 1343-9, 1997 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-9226562

RESUMEN

A new apolar impurity (3,17 alpha-diethinyl-13-ethyl-3,5-gonadiene-17-ol, IIb) was detected and identified in norgestrel with the aid of thin-layer and high-performance chromatography and spectroscopic techniques. IIb is the product of the acid-catalysed dehydration of an overethinylated side product (Ib) of the ethinylation step in the synthesis of norgestrel. IIb can be determined by thin-layer densitometry and high-performance liquid chromatography. Another impurity (17 alpha-ethinyl-13-ethyl-4-gonene-17-ol, IV), originating from a side product of the Birch reduction step in the synthesis of norgestrel was also detected and identified. The spot of IV overlaps with that of IIb in the TLC system of USP XXIII but can be separated and quantification by more selective TLC systems and by gas chromatography.


Asunto(s)
Anticonceptivos Sintéticos Orales/aislamiento & purificación , Norgestrel/aislamiento & purificación , Congéneres de la Progesterona/aislamiento & purificación , Cromatografía Líquida de Alta Presión , Cromatografía en Capa Delgada , Anticonceptivos Sintéticos Orales/síntesis química , Norgestrel/análogos & derivados , Norgestrel/síntesis química , Congéneres de la Progesterona/síntesis química , Análisis Espectral
4.
J Pharm Biomed Anal ; 15(1): 1-5, 1996 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-8895070

RESUMEN

Besides several known impurities in cimetidine, two additional compounds at levels below 0.1% were detected by ion-pair reversed-phase high-performance liquid chromatography (HPLC). The impurities were isolated from crude cimetidine using normal-phase preparative HPLC. 1H and 13C NMR and mass spectrometric investigations revealed the structures of the impurities to be 2,5-bis[(N'-cyano-N"-methyl)guanidinoethylthiomethyl]-4-methylimid azole (VII) and 1,8-bis[(N'-cyano-N"-methyl)guanidino]-3,6-dithiaoctane (VIII). These structures were verified by synthesis of the impurities and comparison of the spectra and chromatographic (HPLC and TLC) retention data of the isolated and synthesized materials.


Asunto(s)
Antiulcerosos/análisis , Cimetidina/análisis , Contaminación de Medicamentos , Imidazoles/aislamiento & purificación , Metilguanidina/análogos & derivados , Antiulcerosos/química , Cromatografía Líquida de Alta Presión , Cimetidina/análogos & derivados , Cimetidina/química , Imidazoles/síntesis química , Espectroscopía de Resonancia Magnética , Espectrometría de Masas , Metilguanidina/síntesis química , Metilguanidina/aislamiento & purificación
5.
Acta Pharm Hung ; 61(2): 77-81, 1991 Mar.
Artículo en Húngaro | MEDLINE | ID: mdl-1887802

RESUMEN

In the course of the estimation of the impurity profile of ethynodiol diacetate, in addition to common impurities such as norethisterone acetate, ethynodiol-3-acetate and alpha-ethynodiol diacetate, two unknown impurities were detected by analytical reversed phase HPLC (C-18 silica and 80% aq. methanol as the eluent) and isolated by normal phase preparative HPLC (silica and 98:2 mixture of hexane and 2-propanol as the eluent). The 1H- and 13C-NMR spectra of the isolated impurities revealed that their structures could be characterized as the E and Z isomers of an analogue of EDDA containing "trimerised acetyl" group at the 17-hydroxy group (structures 4 and 4a). These structures were in good agreement with the extended UV spectra of the impurities and the mass spectra with the m/z 438 peak which can be derived from 4 and 4a by the loss of ketene.


Asunto(s)
Diacetato de Etinodiol/aislamiento & purificación , Cromatografía Líquida de Alta Presión/métodos , Contaminación de Medicamentos
6.
Pharm Res ; 12(2): 295-8, 1995 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-7784348

RESUMEN

We report on a new isomeric impurity of danazol. This impurity designated as isodanazol was detected by reversed-phase high-performance liquid chromatography (HPLC) and thin-layer chromatography (TLC). Its structure was determined after separation by preparative HPLC. Mass spectrometry revealed the isomeric nature of the impurity while the UV spectrum indicated profound difference in the isoxazole moieties. The structure of the isomeric isoxazole ring in isodanazol was determined by NMR spectroscopy using COSY, HETCOR and NOE measurements. The difference between the UV spectra of danazol and isodanazol is explained on the basis of the difference between the aromaticities of their isoxazole rings supported by quantum chemical calculations. The quantitative determination of the impurity down to the 0.05% level can be performed by HPLC, gas chromatography and TLC densitometry.


Asunto(s)
Danazol/análogos & derivados , Danazol/análisis , Cromatografía de Gases , Cromatografía Líquida de Alta Presión , Cromatografía en Capa Delgada , Danazol/aislamiento & purificación , Densitometría , Contaminación de Medicamentos , Isomerismo , Espectroscopía de Resonancia Magnética , Espectrofotometría Ultravioleta
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA